首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1433698篇
  免费   105538篇
  国内免费   6974篇
耳鼻咽喉   20188篇
儿科学   45947篇
妇产科学   40502篇
基础医学   201453篇
口腔科学   39281篇
临床医学   123930篇
内科学   276174篇
皮肤病学   29869篇
神经病学   107181篇
特种医学   55138篇
外国民族医学   367篇
外科学   213587篇
综合类   48379篇
现状与发展   14篇
一般理论   322篇
预防医学   112384篇
眼科学   31831篇
药学   112196篇
  120篇
中国医学   11124篇
肿瘤学   76223篇
  2021年   12248篇
  2019年   11248篇
  2018年   16447篇
  2017年   13117篇
  2016年   13676篇
  2015年   16979篇
  2014年   22450篇
  2013年   33274篇
  2012年   45831篇
  2011年   48663篇
  2010年   30970篇
  2009年   28463篇
  2008年   45293篇
  2007年   48160篇
  2006年   47895篇
  2005年   46058篇
  2004年   43026篇
  2003年   41220篇
  2002年   40171篇
  2001年   61845篇
  2000年   62959篇
  1999年   52991篇
  1998年   14973篇
  1997年   13437篇
  1996年   13689篇
  1995年   12827篇
  1994年   12131篇
  1992年   41961篇
  1991年   41184篇
  1990年   40699篇
  1989年   39478篇
  1988年   36798篇
  1987年   36025篇
  1986年   34365篇
  1985年   32738篇
  1984年   24374篇
  1983年   21181篇
  1982年   12592篇
  1979年   23078篇
  1978年   16148篇
  1977年   13969篇
  1976年   13229篇
  1975年   14470篇
  1974年   17045篇
  1973年   16421篇
  1972年   15631篇
  1971年   14523篇
  1970年   13550篇
  1969年   13044篇
  1968年   12268篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
目的探讨细胞间黏附分子-1(ICAM-1)在实验性自身免疫性脑脊髓炎(EAE)大鼠中表达的动态变化及其作用。方法分别取免疫后第4、6、8、10、12、14、16、18、20天EAE大鼠脑和脊髓制成石蜡切片,行HE染色和ICAM-1半定量免疫组化分析。结果免疫后第8天ICAM-1表达即出现明显上调,早于临床症状的发生;随免疫后时间的延长,ICAM-1表达呈逐渐增高后缓慢下降的变化趋势,并且与EAE大鼠病情评分呈显著正相关(r=0.57,P=0.003)。结论ICAM-1的表达上调可能在EAE发病中具重要作用。  相似文献   
82.
83.
丹参对持续癫痫幼鼠脑损伤保护作用的实验研究   总被引:2,自引:0,他引:2  
李伟  马华 《武警医学》2006,17(3):182-185,F0004
目的 探讨丹参对持续癫痫发作诱发幼鼠脑神经元损伤是否具有保护作用。方法 皮下及腹腔注射贝美格针诱发健康幼龄鼠癫痫持续状态发作。光镜下观察神经元病变情况;电镜观察海马神经元超微结构的改变。结果 持续癫痴组幼鼠脑组织光镜下可见明显的神经元病变。电镜下可见海马区神经元的超微结构病变。丹参治疗组神经元病变均轻于持续癫痴组;而正常对照组未见类似病变。结论 丹参在组织、细胞和亚细胞水平对持续癫病幼鼠脑神经元损伤具有一定的保护作用,为临床有效防治小儿惊厥性脑损伤提供了可靠的实验依据。  相似文献   
84.
166Ho-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetramethylene-phosphonate (DOTMP) is a tetraphosphonate molecule radiolabeled with 166Ho that localizes to bone surfaces. This study evaluated pharmacokinetics and radiation-absorbed dose to all organs from this beta-emitting radiopharmaceutical. METHODS: After two 1.1-GBq administrations of 166Ho-DOTMP, data from whole-body counting using a gamma-camera or uptake probe were assessed for reproducibility of whole-body retention in 12 patients with multiple myeloma. The radiation-absorbed dose to normal organs was estimated using MIRD methodology, applying residence times and S values for 166Ho. Marrow dose was estimated from measured activity retained after 18 h. The activity to deliver a therapeutic dose of 25 Gy to the marrow was determined. Methods based on region-of-interest (ROI) and whole-body clearance were evaluated to estimate kidney activity, because the radiotracer is rapidly excreted in the urine. The dose to the surface of the bladder wall was estimated using a dynamic bladder model. RESULTS: In clinical practice, gamma-camera methods were more reliable than uptake probe-based methods for whole-body counting. The intrapatient variability of dose calculations was less than 10% between the 2 tracer studies. Skeletal uptake of 166Ho-DOTMP varied from 19% to 39% (mean, 28%). The activity of 166Ho prescribed for therapy ranged from 38 to 67 GBq (1,030-1,810 mCi). After high-dose therapy, the estimates of absorbed dose to the kidney varied from 1.6 to 4 Gy using the whole-body clearance-based method and from 8.3 to 17.3 Gy using the ROI-based method. Bladder dose ranged from 10 to 20 Gy, bone surface dose ranged from 39 to 57 Gy, and doses to other organs were less than 2 Gy for all patients. Repetitive administration had no impact on tracer biodistribution, pharmacokinetics, or organ dose. CONCLUSION: Pharmacokinetics analysis validated gamma-camera whole-body counting of 166Ho as an appropriate approach to assess clearance and to estimate radiation-absorbed dose to normal organs except the kidneys. Quantitative gamma-camera imaging is difficult and requires scatter subtraction because of the multiple energy emissions of 166Ho. Kidney dose estimates were approximately 5-fold higher when the ROI-based method was used rather than the clearance-based model, and neither appeared reliable. In future clinical trials with 166Ho-DOTMP, we recommend that dose estimation based on the methods described here be used for all organs except the kidneys. Assumptions for the kidney dose require further evaluation.  相似文献   
85.
MR T2加权成像显示胆囊壁增厚点状高信号的意义   总被引:1,自引:1,他引:0  
目的研究病理组织学证实的胆囊腺肌瘤病、慢性胆囊炎和管壁增厚型胆囊腺癌在MRL加权成像(T2WI)显示病变胆囊壁点状高信号的特征。方法38例患者(胆囊腺肌瘤病16例,慢性胆囊炎13例,管壁增厚型胆囊腺癌9例),每例均进行了MR常规T1WI、常规T2WI和3mm薄层T2WI及MR胰胆管成像(MRCP)。所有患者均接受了胆囊切除手术。2名高年资放射科医生共同分析不同序列MRI,观察胆囊壁增厚及T2WI显示病变胆囊壁点状高信号的不同表现,将观察结果与病理组织学检查所见对照。结果所有患者的胆囊壁均明显增厚,厚度范围5~15mm,平均9mm。T2WI显示病变胆囊壁存在各种各样的点状高信号,在胆囊腺肌瘤病,点状高信号分布于整个增厚的胆囊壁,且数量较多(5~15个/cm^2),较大(直径2~7mm),边界清楚,呈现中等至明显高信号;在慢性胆囊炎,点状高信号主要位于增厚胆囊壁的黏膜侧,数量较少(3~5个/cm^2),较小(直径2~4mm),边界清楚,呈中等至明显高信号;在管壁增厚型胆囊腺癌,点状高信号边界欠清,呈现稍高信号,其数量和大小差异较大,分布范围取决于癌组织浸润胆囊壁的深度。结论胆囊腺肌瘤病、慢性胆囊炎和管壁增厚型胆囊腺癌在T2WI呈现的点状高信号有一定差别,正确识别这些点状高信号的特征有助于鉴别诊断良恶性胆囊壁增厚。  相似文献   
86.
BACKGROUND CONTEXT: Substantial variation exists regarding the use of sedation before interventional spine techniques. Patient preference should play an important role in decision making regarding the need for sedation. However, little is known about patients' anxiety levels before spinal injections and their perceptions about the necessity of sedation. PURPOSE: To determine patient perception for need for sedation before epidural steroid injections and zygapophyseal joint injections. STUDY DESIGN/SETTING: Survey of consecutive spinal injection patients in an outpatient spine center. PATIENT SAMPLE: 500 consecutive lumbar, thoracic, and cervical patients receiving spinal injections. OUTCOME MEASURES: A 12-item questionnaire assessing patients' perceived anxiety before to a spinal injection. METHODS: Subjects were given the questionnaire after their spinal injection. Percentages requesting sedation for a first and potential second procedure were assessed. Additionally, anxiety level and pain rating, location of injection, age, sex, and other medication use were analyzed to determine the effect on the request for sedation. RESULTS: 17% of patients questioned requested sedation before an injection, and 28% would request sedation if they were to have a second injection. CONCLUSIONS: Routine sedation before diagnostic and therapeutic injections is not necessary as the majority of patients would not request sedation before the procedure when given the option. However, in some patients sedation is indicated, and all patients would benefit from educational material on sedation before the injection.  相似文献   
87.
Wound healing involves a number of cellular and molecular events, many of which are controlled by soluble growth factors. In the process of healing, hepatocyte growth factor, a cytokine known to act as mitogen, motogen, and morphogen, has been postulated to play multiple roles during several stages of this complex biological process. Produced primarily by stromal fibroblasts, hepatocyte growth factor regulates angiogenesis, vascular permeability, cell migration, matrix deposition and degradation, and other biological processes. The current article discusses recent progress in understanding the multiple roles played by this growth factor in tissue repair.  相似文献   
88.
AIMS: To report clinical outcomes of a large series of cases with advanced thyroid cancer. STUDY DESIGN: Three hundred and eighty-five patients at the UICC stages III and IV were selected for the study with thyroid cancer. RESULTS: Papillary carcinoma and sclerosing carcinoma have better survival than the Hürthle cell and insular types. Lymphatic metastasis does not appear to worsen the prognosis. All the tumour forms offer the chance of long survival. CONCLUSIONS: Surgical treatment is the primary treatment of thyroid carcinoma. The combined treatments of surgery, metabolic beam therapy, suppressive hormone therapy, radiotherapy and chemotherapy cure a high percentage of patients with the tumour at an advanced stage.  相似文献   
89.
The new treatment strategy for Peritoneal Surface Malignancy combines a cytoreductive surgery and perioperative intraperitoneal chemotherapy. Cytoreduction removes all macroscopic tumor. Intraperitoneal chemotherapy avoids implantation of microscopic residual tumor cells on intra-abdominal surfaces when it is administered intraoperatively and/or early in the postoperative period. Delivering cytotoxic drugs directly into the peritoneal cavity maximizes dose intensity and minimizes systemic toxicity. Hyperthermia is selectively cytotoxic for malignant cells and potentiates the effect of chemotherapy. Implementation of this procedure makes the perioperative personnel to face a risk of exposure to cytotoxic agents. Furthermore, peritonectomies and electro-evaporation of tumor nodules are performed with high voltage electrocautery, generating a large amount of surgical smoke during several hours. Inhalation of these fumes may be also a risk for healthcare workers. In this article, we analyse in depth these new risks of the operating room personnel, we review the literature, and we give guidelines for secure performance of cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy, as well as for early postoperative intraperitoneal chemotherapy administration. These new procedures are safe techniques for patients and healthcare workers provided adequate policies are adopted to avoid occupational exposure.  相似文献   
90.
灾难的时代错误:灾害医学的过去、现在和将来(一)   总被引:1,自引:0,他引:1  
灾难,特别是地震、火山、洪水以及与战争有关的事件如饥饿和流行性传染病,是人类有记录的经历的一部分。从意大利庞贝的火山爆发,到约翰斯顿的洪水、第二次世界大战和黑色瘟疫,到西班牙流感,都发生了灾难,这不会被传说和历史书籍长期忘却。不过,在20世纪中叶以前,那些灾难的发生相对较少,且相距时间较长。从20世纪中叶以来,灾难的本质发生了变化。从恐怖分子使用“新技术”,到与气候有关的导致亿万美元经济损失的事件,表明这个世界正在发生变化。仅仅在最近的50~60年间,造成多种多样的伤亡事件,其危险性和频率的增加引人注目,并且注定要在接…  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号